🔴 Syncom Formulations is trading 5% down with no clear catalyst identified

Syncom Formulations is trading 5.03% lower at ₹22.07, with no clear company-specific announcement explaining the decline.

• The Nifty Pharma was down 0.82% in an October 13, 2026 market report, but this does not establish the cause of the stock’s larger fall.
• Available reporting does not establish a direct catalyst or trading-volume explanation.
• Recent AGM and dividend announcements predated the session, as did the company filings surfaced.